Copyright
©The Author(s) 2018.
World J Gastroenterol. Aug 14, 2018; 24(30): 3313-3329
Published online Aug 14, 2018. doi: 10.3748/wjg.v24.i30.3313
Published online Aug 14, 2018. doi: 10.3748/wjg.v24.i30.3313
microRNA | Changes inGC | Changes inGC tissue | Controls (n) | GC(n) | TNM reported | ROC | Validation | Source (Pl/Bl/Se) | qPCR | Normalization(qPCR) | Ref. |
let-7a | ↓ | ↓ | 30 | 69 | Yes | Yes | Plasma | TaqMan | RNU6b | [56] | |
↓ | ↓ | 45 | 80 | Yes | Serum | SYBR | RNU6b | [57] | |||
↔ | 30 | 30 | Yes | Plasma | TaqMan | RNU6b | [58] | ||||
let-7c | ↔ | 202 | 214 | No | Serum | SYBR | standard curve | [59] | |||
let-7e | ↑ | 82 | 82 | No | 0.7 | Yes | Serum | TaqMan | cel-miR-39 | [60] | |
let-7f | ↔ | 30 | 30 | Yes | Plasma | TaqMan | RNU6b | [58] | |||
↑ | 202 | 214 | No | Serum | SYBR | standard curve | [59] | ||||
let-7g | ↔ | 30 | 30 | No | Serum | SYBR | miR-16 | [61] | |||
let-7i | ↑ | 202 | 214 | No | Serum | SYBR | standard curve | [59] | |||
miR-1 | ↑ | 127 | 164 | Yes | Serum | TaqMan | volume | [62] | |||
↔ | 30 | 30 | No | Plasma | SYBR | cel-miR-39 | [63] | ||||
miR-100 | ↑ | 47 | 50 | Yes | 0.71 | Serum | TaqMan | RNU6b | [52] | ||
miR-103 | ↑ | 14 | 17 | No | Plasma | SYBR | Sp6 | [64] | |||
↔ | 50 | 50 | No | 0.548 | Plasma | SYBR | cel-miR-39 | [65] | |||
miR-106a | ↑ | 30 | 69 | Yes | Yes | Plasma | TaqMan | RNU6b | [56] | ||
↑ | 27 | 41 | No | 0.684 | PBMC | SYBR | RNU6b | [66] | |||
↔ | 30 | 30 | No | Plasma | SYBR | cel-miR-39 | [63] | ||||
↑ | ↑ | 22 | 48 | NA | Serum | NA | NA | [67] | |||
↑ | ↑ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39 miR-191-5p | [68] | ||
↑ | 130 | 130 | No | 0.786 | Yes | Serum + Exosomes | TaqMan | cel-miR-39 | [69] | ||
miR-106b | ↑ | ↑ | 30 | 69 | Yes | 0.721 | Yes | Plasma | TaqMan | RNU6b | [56] |
↑ | 90 | 90 | Yes | 0.773 | Yes | Plasma | SYBR | cel-miR-39 | [63] | ||
↑ | 15 | 31 | Yes | Serum | TaqMan | cel-miR-39 | [70] | ||||
↑ | ↑ | 20 | 20 | Yes | Plasma | TaqMan | cel-miR-39 RNU6b | [71] | |||
↓ | 36 | 40 | Yes | 0.856 | Serum | SYBR | QuantoEC | [72] | |||
↑ | 65 | 65 | Yes | 0.898 | Plasma | TaqMan | RNU6b | [73] | |||
miR-107 | ↑ | ↑ | 36 | 36 | No | 0.63 | Serum | SYBR | 5srRNA | [74] | |
↑ | 14 | 14 | Yes | Serum | TaqMan | RNU6b | [75] | ||||
↔ | 50 | 50 | No | 0.563 | Plasma | SYBR | cel-miR-39 | [65] | |||
miR-10b-5p | ↑ | ↑ | 167 | 203 | Yes | 0.627 | Yes | Serum + exosomes | SYBR | cel-miR-39 miR-16 | [76] |
miR-122 | ↔ | 36 | 96 | Yes | Plasma | SYBR | ath-miR-159a | [77] | |||
miR-1233 | ↓ | 3 | 3 | No | Plasma | SYBR | RNU6b | [78] | |||
miR-130a | ↑ | ↑ | 41 | 41 | No | 0.905 | Serum | SYBR | RNU6B | [79] | |
↑ | ↑ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39 miR-191-5p | [68] | ||
miR-132-3p | ↑ | ↑ | 167 | 203 | Yes | 0.652 | Yes | Serum + exosomes | SYBR | cel-miR-39 miR-16 | [76] |
miR-139 | ↓ | ↑ | 18 | 25 | No | 0.940 | Plasma | SYBR | RNU6b | [80] | |
miR-140-5p | ↑ | 50 | 50 | Yes | Plasma | SYBR | RNU6B | [81] | |||
miR-141 | ↓ | 3 | 3 | No | Plasma | SYBR | RNU6b | [78] | |||
↓ | 14 | 17 | No | Plasma | SYBR | Sp6 | [64] | ||||
miR-142-3p | ↓ | 285 | 285 | Yes | 0.839 | Yes | Plasma | TaqMan | cel-miR-39 | [47] | |
miR-143-3p | ↔ | 73 | 206 | Yes | Yes | Serum | SYBR | RNU6b | [82] | ||
miR-144 | ↓ | ↓ | 40 | 96 | Yes | 0.821 | Serum | SYBR | RNU6b | [83] | |
miR-146a | ↔ | 15 | 31 | Yes | Serum | TaqMan | cel-miR-39 | [70] | |||
↔ | 73 | 206 | Yes | Yes | Serum | SYBR | RNU6b | [82] | |||
↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39 miR-191-5p | [68] | ||
miR-146b | ↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39 miR-191-5p | [68] | |
miR-148a | ↔ | 15 | 31 | Yes | Serum | TaqMan | cel-miR-39 | [70] | |||
↓ | 285 | 285 | Yes | 0.842 | Yes | Plasma | TaqMan | cel-miR-39 | [47] | ||
↓ | ↓ | 39 | 38 | Yes | 0.349 | Plasma | TaqMan | miR-16-5p | [26] | ||
miR-151-5p | ↑ | 130 | 230 | Yes | 0.625 | Yes | Plasma | TaqMan | RNU6b | [58] | |
miR-155 | ↑ | 20 | 30 | No | Yes | Plasma | TaqMan | RNU6b | [84] | ||
↔ | 15 | 15 | No | Plasma | TaqMan | RNU6b | [85] | ||||
miR-15b-5p | ↑ | ↑ | 100 | 100 | No | Plasma | SYBR | RNU6b | [86] | ||
miR-16 | ↑ | 106 | 160 | Yes | 0.768-0.925 | Yes | Plasma | TaqMan | cel-miR-39 | [51] | |
↑ | 47 | 50 | Yes | 0.90 | Serum | TaqMan | RNU6b | [52] | |||
↓ | 129 | 189 | Yes | 0.772 | Yes | Plasma | TaqMan | cel-miR-39 miR-16-5p | [53] | ||
miR-17 | ↑ | 27 | 41 | No | 0.743 | PBMC | SYBR | RNU6b | [66] | ||
↓ | 36 | 40 | Yes | 0.879 | Serum | SYBR | QuantoEC | [72] | |||
↑ | 30 | 69 | Yes | Yes | Plasma | TaqMan | RNU6b | [56] | |||
↔ | 30 | 30 | No | Plasma | SYBR | cel-miR-39 | [63] | ||||
↔ | 20 | 20 | No | Serum + exosomes | TaqMan | cel-miR-39 | [69] | ||||
miR-181a | ↑ | ↑ | 18 | 25 | No | 0.882 | Plasma | SYBR | RNU6b | [80] | |
miR-181b | ↓ | 89 | 92 | Yes | Yes | Serum | SYBR | miR-16 | [61] | ||
miR-181c | ↑ | ↑ | 60 | 30 | No | Plasma | SYBR | RNU6b | [87] | ||
miR-185 | ↑ | ↑ | 109 | 133 | Yes | 0.65 | Yes | Plasma | SYBR | cel-miR-39 RNU6b | [88] |
↑ | ↔ | 167 | 203 | Yes | 0.637 | Yes | Serum + exosomes | SYBR | cel-miR-39 miR-16 | [76] | |
miR-187-3p | ↑ | 61 | 61 | Yes | Yes | Serum | SYBR | RNU6b | [89] | ||
miR-18a | ↑ | 50 | 50 | Yes | Plasma | SYBR | RNU6B | [81] | |||
↑ | ↑ | 65 | 104 | Yes | 0.805 | Plasma | TaqMan | RNU6b | [90] | ||
miR-191 | ↑ | 82 | 82 | No | 0.63 | Yes | Serum | TaqMan | cel-miR-39 | [60] | |
↑ | 58 | 57 | Yes | 0.849 | Serum | TaqMan | miR-16 | [49] | |||
miR-192 | ↔ | 36 | 96 | Yes | Plasma | SYBR | ath-miR-159a | [77] | |||
miR-194 | ↑ | 3 | 3 | No | Plasma | SYBR | RNU6b | [78] | |||
↔ | 50 | 50 | No | 0.512 | Plasma | SYBR | cel-miR-39 | [65] | |||
miR-195 | ↓ | 285 | 285 | Yes | 0.765 | Yes | Plasma | TaqMan | cel-miR-39 | [47] | |
↓ | ↓ | 36 | 62 | Yes | Yes | Serum | SYBR | RNU6b | [91] | ||
↓ | 190 | 20 | No | Plasma | (TaqMan) | global mean | [92] | ||||
↑ | ↔ | 167 | 203 | Yes | 0.683 | Yes | Serum + exosomes | SYBR | cel-miR-39 miR-16 | [76] | |
mir-196a | ↓ | ↑ | 14 | 17 | No | Plasma | SYBR | Sp6 | [64] | ||
↑ | ↑ | 126 | 98 | Yes | 0.864 | Plasma | SYBR | miR-16 | [93] | ||
miR-196b | ↑ | ↑ | 126 | 98 | Yes | 0.811 | Plasma | SYBR | miR-16 | [93] | |
miR-198 | ↔ | 30 | 30 | Yes | Plasma | TaqMan | RNU6b | [58] | |||
miR-199a-3p | ↑ | 70 | 80 | Yes | 0.818 | Yes | Plasma | TaqMan | RNU6b | [94] | |
↑ | 130 | 230 | Yes | 0.837 | Yes | Plasma | TaqMan | RNU6b | [58] | ||
↑ | 50 | 50 | Yes | Plasma | SYBR | RNU6B | [81] | ||||
miR-19a | ↑ | ↑ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39 miR-191-5p | [68] | |
miR-19b | ↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39 miR-191-5p | [68] | |
↑ | 3 | 3 | No | Plasma | SYBR | RNU6b | [78] | ||||
↓ | 129 | 189 | Yes | 0.749 | Yes | Plasma | TaqMan | cel-miR-39, miR-16-5p | [53] | ||
↑ | 130 | 130 | No | 0.769 | Yes | Serum + exosomes | TaqMan | cel-miR-39 | [69] | ||
miR-200b | ↓ | 14 | 17 | No | Plasma | SYBR | Sp6 | [64] | |||
miR-200c | ↑ | 15 | 52 | Yes | 0.715 | blood | SYBR | RNU6b 5SrRNA | [95] | ||
↑ | 100 | 98 | Yes | Serum | SYBR | RNU6b | [96] | ||||
miR-203 | ↓ | 89 | 92 | Yes | Yes | Serum | SYBR | miR-16 | [61] | ||
↓ | 22 | 130 | Yes | 0.707 | Yes | Serum | TaqMan | cel-miR-39 | [97] | ||
miR-204 | ↓ | 40 | 115 | Yes | Yes | Serum | SYBR | RNU6b | [98] | ||
miR-206 | ↓ | 150 | 150 | Yes | 0.89 | Serum | TaqMan | cel-miR-39 | [99] | ||
miR-20a | ↑ | 127 | 164 | Yes | Serum | TaqMan | volume | [62] | |||
↑ | 90 | 90 | Yes | 0.859 | Yes | Plasma | SYBR | cel-miR-39 | [63] | ||
↑ | ↑ | 30 | 30 | No | Plasma | SYBR | RNU6b | [100] | |||
↑ | ↑ | 109 | 133 | Yes | 0.67 | Yes | Plasma | SYBR | cel-miR-39 RNU6b | [88] | |
↑ | ↑ | 28 | 28 | No | Plasma | SYBR | RNU6b | [101] | |||
↑ | ↔ | 167 | 203 | Yes | 0.637 | Yes | Serum + exosomes | SYBR | cel-miR-39 miR-16 | [76] | |
↑ | 12 | 12 | No | Serum | SYBR | cel-miR-39 | [102] | ||||
miR-21 | ↑ | 30 | 69 | Yes | Yes | Plasma | TaqMan | RNU6b | [56] | ||
↑ | 20 | 53 | Yes | 0.853 | Blood | SYBR | RNU6b | [103] | |||
↑ | 70 | 70 | Yes | 0.794 | Yes | Plasma | TaqMan | cel-miR-39 | [104] | ||
↑ | 39 | 30 | Yes | 0.81 | Serum | SYBR | miR-16 | [105] | |||
↑ | 20 | 40 | Yes | Serum | All-in-one | Volume miR-16, miR-93 | [48] | ||||
↔ | 90 | 90 | Yes | Plasma | SYBR | cel-miR-39 | [63] | ||||
↔ | 15 | 31 | Yes | Serum | TaqMan | cel-miR-39 | [70] | ||||
↔ | 15 | 15 | No | Plasma | TaqMan | RNU6b | [85] | ||||
↑ | 50 | 50 | Yes | 0.912 | Serum | SYBR | RNU6b | [106] | |||
↑ | 50 | 50 | Yes | 0.898 | PBMC | SYBR | RNU6b | [106] | |||
↑ | ↑ | 14 | 17 | No | Plasma | SYBR | Sp6 | [64] | |||
↑ | 89 | 92 | Yes | Yes | Serum | SYBR | miR-16 | [61] | |||
↑ | ↑ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39 miR-191-5p | [68] | ||
miR-210 | ↑ | ↑ | 109 | 133 | Yes | 0.75 | Yes | Plasma | SYBR | cel-miR-39 RNU6b | [88] |
miR-212 | ↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39 miR-191-5p | [68] | |
miR-218 | ↓ | 70 | 70 | Yes | 0.743 | Yes | Plasma | TaqMan | cel-miR-39 | [104] | |
↓ | 56 | 68 | Yes | Serum | SYBR | cel-miR-39 | [107] | ||||
miR-220 | ↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39 miR-191-5p | [68] | |
miR-221 | ↑ | 82 | 82 | No | 0.7 | Yes | Serum | TaqMan | cel-miR-39 | [60] | |
↑ | 90 | 90 | Yes | 0.796 | Yes | Plasma | SYBR | cel-miR-39 | [63] | ||
↑ | 14 | 17 | No | Plasma | SYBR | Sp6 | [64] | ||||
miR-222 | ↑ | 82 | 82 | No | 0.65 | Yes | Serum | TaqMan | cel-miR-39 | [60] | |
↑ | 56 | 114 | Yes | 0.85 | Plasma | TaqMan | RNU6b | [108] | |||
miR-223 | ↑ | 70 | 70 | Yes | 0.91 | Yes | Plasma | TaqMan | cel-miR-39 | [104] | |
↑ | 15 | 31 | Yes | Serum | TaqMan | cel-miR-39 | [70] | ||||
↑ | 47 | 50 | Yes | 0.85 | Serum | TaqMan | RNU6b | [52] | |||
↑ | ↑ | 50 | 50 | Yes | 0.81 | Plasma | SYBR | RNU6b | [109] | ||
↑ | 3 | 3 | No | Plasma | SYBR | RNU6b | [78] | ||||
↑ | ↑ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39 miR-191-5p | [68] | ||
↑ | ↑ | 20 | 15 | Yes | Plasma | NCode | cel-miR-39/-54/-238; miR-16 | [110] | |||
↑ | ↑ | 39 | 38 | Yes | 0.671 | Plasma | TaqMan | miR-16-5p | [26] | ||
miR-23a | ↑ | 14 | 17 | No | Plasma | SYBR | Sp6 | [64] | |||
miR-23b | ↑ | 50 | 138 | Yes | 0.80 | Plasma | SYBR | RNU6b | [111] | ||
miR-25 | ↔ | 10 | 10 | No | Plasma | TaqMan | cel-miR-39 | [104] | |||
↑ | 106 | 160 | Yes | 0.694-0.925 | Yes | Plasma | TaqMan | cel-miR-39 | [51] | ||
↑ | ↑ | 20 | 20 | Yes | Plasma | TaqMan | cel-miR-39; RNU6b | [71] | |||
↑ | ↑ | 109 | 133 | Yes | 0.65 | Yes | Plasma | SYBR | cel-miR-39; RNU6b | [88] | |
↔ | ↑ | 70 | 70 | Yes | Plasma | TaqMan | RNU6B | [112] | |||
↑ | 14 | 14 | Yes | Serum | TaqMan | RNU6b | [75] | ||||
↑ | 65 | 65 | Yes | 0.817 | Plasma | TaqMan | RNU6b | [73] | |||
miR-26a | ↓ | 285 | 285 | Yes | 0.882 | Yes | Plasma | TaqMan | cel-miR-39 | [47] | |
miR-26b | ↔ | 30 | 30 | Yes | Plasma | TaqMan | RNU6b | [58] | |||
miR-27a | ↑ | 127 | 164 | Yes | Serum | TaqMan | volume | [62] | |||
↑ | 82 | 82 | No | 0.67 | Yes | Serum | TaqMan | cel-miR-39 | [60] | ||
↔ | 30 | 30 | No | Plasma | SYBR | cel-miR-39 | [63] | ||||
↔ | 15 | 31 | Yes | Serum | TaqMan | cel-miR-39 | [70] | ||||
↑ | ↑ | 35 | 35 | Yes | 0.70 | Yes | Plasma | TaqMan | RNU6b | [85] | |
miR-27b | ↑ | 82 | 82 | No | 0.66 | Yes | Serum | TaqMan | cel-miR-39 | [60] | |
miR-296 | ↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39; miR-191-5p | [68] | |
↑ | ↑ | 167 | 203 | Yes | 0.652 | Yes | Serum + exosomes | SYBR | cel-miR-39 miR-16 | [76] | |
miR-30a-5p | ↔ | 20 | 20 | No | Serum + exosomes | TaqMan | cel-miR-39 | [69] | |||
miR-30c | ↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39; miR-191-5p | [68] | |
miR-31 | ↓ | 89 | 92 | Yes | Yes | Serum | SYBR | miR-16 | [61] | ||
miR-32 | ↑ | ↑ | 40 | 40 | No | Plasma | SYBR | RNU6b | [113] | ||
miR-323-3p | ↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39; miR-191-5p | [68] | |
miR-331 | ↑ | ↑ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39; miR-191-5p | [68] | |
miR-335 | ↓ | ↓ | 7 | 4 | No | Plasma | TaqMan | RNU6b | [114] | ||
miR-34 | ↔ | 30 | 30 | No | Plasma | SYBR | cel-miR-39 | [63] | |||
miR-346 | ↓ | 14 | 17 | No | Plasma | SYBR | Sp6 | [64] | |||
miR-34a | ↑ | 127 | 164 | Yes | Serum | TaqMan | volume | [62] | |||
miR-365 | ↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39; miR-191-5p | [68] | |
miR-370 | ↑ | ↑ | 12 | 40 | Yes | 0.79 | Plasma | TaqMan | miR-16 | [115] | |
miR-371-5p | ↑ | 61 | 61 | Yes | Yes | Serum | SYBR | RNU6b | [89] | ||
miR-374 | ↑ | ↑ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39; miR-191-5p | [68] | |
miR-375 | ↓ | ↓ | 20 | 20 | No | 0.835 | Serum | TaqMan | RNU6b | [116] | |
↓ | ↓ | 39 | 38 | Yes | 0.32 | Plasma | TaqMan | miR-16-5p | [26] | ||
miR-376a | ↔ | ↑ | 108 | 65 | Yes | Plasma | TaqMan | RNU6B | [117] | ||
miR-376c | ↑ | 82 | 82 | No | 0.71 | Yes | Serum | TaqMan | cel-miR-39 | [60] | |
↔ | 30 | 30 | No | Plasma | SYBR | cel-miR-39 | [63] | ||||
↑ | ↑ | 108 | 65 | Yes | 0.77 | Plasma | TaqMan | RNU6B | [117] | ||
miR-378 | ↑ | ↓ | 61 | 61 | Yes | 0.861 | Yes | Serum | SYBR | RNU6b | [89] |
↔ | 30 | 30 | No | Plasma | SYBR | cel-miR-39 | [63] | ||||
↓ | 14 | 17 | No | Plasma | SYBR | Sp6 | [64] | ||||
miR-421 | ↑ | 17 | 40 | Yes | 0.773 | PBMC | SYBR | RNU6b | [118] | ||
↑ | 50 | 50 | No | Yes | Serum (?) | SYBR | RNU6b | [119] | |||
↑ | 90 | 90 | No | 0.779 | Serum | SYBR | RNU6b | [120] | |||
↑ | 90 | 90 | No | 0.821 | PBMC | SYBR | RNU6b | [120] | |||
miR-423-5p | ↑ | 127 | 164 | Yes | Serum | TaqMan | volume | [62] | |||
↔ | 30 | 30 | No | Plasma | SYBR | cel-miR-39 | [63] | ||||
miR-425 | ↔ | 58 | 57 | Yes | Serum | TaqMan | miR-16 | [49] | |||
miR-433 | ↔ | 15 | 31 | Yes | Serum | TaqMan | cel-miR-39 | [70] | |||
↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39; miR-191-5p | [68] | ||
miR-451 | ↑ | ↓ | 30 | 56 | Yes | 0.96 | Yes | Plasma | TaqMan | RNU6b | [54] |
↔ | 90 | 90 | Yes | Plasma | SYBR | cel-miR-39 | [63] | ||||
↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39; miR-191-5p | [68] | ||
↑ | 106 | 160 | Yes | 0.790-0.850 | Yes | Plasma | TaqMan | cel-miR-39 | [51] | ||
↔ | 73 | 206 | Yes | Yes | Serum | SYBR | RNU6b | [82] | |||
miR-484 | ↓ | ↓ | 14 | 17 | No | Plasma | SYBR | Sp6 | [64] | ||
miR-486 | ↑ | ↓ | 30 | 56 | Yes | 0.92 | Yes | Plasma | TaqMan | RNU6b | [54] |
↔ | 30 | 30 | No | Plasma | SYBR | cel-miR-39 | [63] | ||||
↑ | 106 | 160 | Yes | 0.779-0.863 | Yes | Plasma | TaqMan | cel-miR-39 | [51] | ||
↓ | 14 | 17 | No | Plasma | SYBR | Sp6 | [64] | ||||
miR-501-3p | ↔ | 73 | 206 | Yes | Yes | Serum | SYBR | RNU6b | [82] | ||
miR-518d | ↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39; miR-191-5p | [68] | |
miR-518f | ↑ | ↔ | 20 | 20 | Yes | Yes | Serum | TaqMan | cel-miR-39; miR-191-5p | [68] | |
miR-627 | ↑ | ↑ | 111 | 123 | Yes | 0.937 | Yes | Plasma | SYBR | RNU6B | [81] |
miR-629 | ↑ | ↑ | 111 | 123 | Yes | 0.912 | Yes | Plasma | SYBR | RNU6B | [81] |
miR-652 | ↑ | ↑ | 111 | 123 | Yes | 0.918 | Yes | Plasma | SYBR | RNU6B | [81] |
miR-720 | ↔ | 30 | 30 | Yes | Plasma | TaqMan | RNU6b | [58] | |||
miR-744 | ↑ | 82 | 82 | No | 0.74 | Yes | Serum | TaqMan | cel-miR-39 | [60] | |
↔ | 30 | 30 | No | Plasma | SYBR | cel-miR-39 | [63] | ||||
miR-92a | ↑ | 106 | 160 | Yes | 0.732-0.913 | Yes | Plasma | TaqMan | cel-miR-39 | [51] | |
↓ | 89 | 92 | Yes | Yes | Serum | SYBR | miR-16 | [61] | |||
miR-92b | ↑ | ↑ | 109 | 133 | Yes | 0.69 | Yes | Plasma | SYBR | cel-miR-39; RNU6b | [88] |
miR-93 | ↑ | ↑ | 20 | 20 | Yes | Plasma | TaqMan | cel-miR-39; RNU6b | [71] | ||
↑ | 65 | 65 | Yes | 0.756 | Plasma | TaqMan | RNU6b | [73] | |||
miR-940 | ↓ | ↓ | 105 | 115 | Yes | 0.96 | Yes | Plasma | SYBR | miR-16 | [55] |
Ref. | Year | Source | Extraction Kit | Platform | Sample Origin | GC(number of technical runs) | Controls (number of technical runs) | pooled samples | GC(number ofpooled samples) | Controls (number ofpooled samples) |
Liu et al[62] | 2011 | Serum | phen/chlor | Solexa | China | 1 | 1 | Yes | 20 | 20 |
Song et al[60] | 2012 | Serum | miRNeasy | qPCR-array | China | 1 | 1 | Yes | 14 | 14 |
Liu et al[89] | 2012 | Serum | mirVana | Agilent | China | 7 | 10 | No | ||
Konishi et al[54] | 2012 | Plasma | mirVana | microarray | Japan | 3 | 3 | No | ||
Gorur et al[92] | 2013 | Plasma | high-pure miRNA Isolation | TaqMan Array | Turkey | 1 | 1 | Yes | 20 | 190 |
Shah et al[121] | 2013 | Blood | miRNeasy | Geniom Biochip | Poland | 1 | 1 | Yes | 8 | 19 |
Li et al[58] | 2013 | Plasma | mirVana | Agilent | China | 20 | 20 | No | ||
Zhu et al[51] | 2014 | Plasma | miRNeasy | TaqMan Array | China | 1 | 1 | Yes | 40 | 40 |
Zhang et al[53] | 2015 | Plasma | mirVana | Agilent | China | 16 | 18 | No | ||
Zhou et al[88] | 2015 | Plasma | mirVana | Exiqon | China | 3 | 1 | Yes | 30 | 10 |
Shin et al[81] | 2015 | Plasma | Trizol miRNeasy | miRCURY LNA | China | 5 | 5 | No | ||
Zhang et al[78] | 2015 | Plasma | mirVana | Agilent | China | 3 | 3 | No | ||
Liu et al[55] | 2016 | Plasma | miRNeasy | miRCURY LNA | Hong-Kong | 5 | 5 | No | ||
Qiu et al[47] | 2016 | Plasma | miRNeasy | Agilent | China | 1 | 1 | Yes | 5 | 5 |
Treece et al[64] | 2016 | Plasma | miRCURY | GastroGenus miR Panel | United States | 17 | 14 | No | ||
Jiang et al[82] | 2017 | Serum | unknown | miSeq | China | 2 | 1 | Yes | 20 | 10 |
Huang et al[76] | 2017 | Serum | mirVana | Exiqon | China | 3 | 1 | Yes | 30 | 10 |
Sierzega et al[68] | 2017 | Serum | miRNA ABC Purification | TaqMan Array | Poland | 20 | 20 | No |
- Citation: Link A, Kupcinskas J. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives. World J Gastroenterol 2018; 24(30): 3313-3329
- URL: https://www.wjgnet.com/1007-9327/full/v24/i30/3313.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i30.3313